Abstract
This paper describes an investigation into the influence of microporosity on early osseointegration and final bone volume within porous hydroxyapatite (HA) bone graft substitutes (BGS). Four paired grades of BGS were studied, two (HA70-1 and HA70-2) with a nominal total porosity of 70% and two (HA80-1 and HA80-2) with a total-porosity of 80%. Within each of the total-porosity paired grades the nominal volume fraction of microporosity within the HA struts was varied such that the strut porosity of HA70-1 and HA80-1 was 10% while the strut-porosity of HA70-2 and HA80-2 was 20%. Cylindrical specimens, 4.5 mm diameter × 6.5 mm length, were implanted in the femoral condyle of 6 month New Zealand White rabbits and retrieved for histological, histomorphometric, and mechanical analysis at 1, 3, 12 and 24 weeks. Histological observations demonstrated variation in the degree of capillary penetration at 1 week and bone morphology within scaffolds 3–24 weeks. Moreover, histomorphometry demonstrated a significant increase in bone volume within 20% strut-porosity scaffolds at 3 weeks and that the mineral apposition rate within these scaffolds over the 1–2 week period was significantly higher. However, an elevated level of bone volume was only maintained at 24 weeks in HA80-2 and there was no significant difference in bone volume at either 12 or 24 weeks for 70% total-porosity scaffolds. The results of mechanical testing suggested that this disparity in behaviour between 70 and 80% total-porosity scaffolds may have reflected variations in scaffold mechanics and the degree of reinforcement conferred to the bone-BGS composite once fully integrated. Together these results indicate that manipulation of the levels of microporosity within a BGS can be used to accelerate osseointegration and elevate the equilibrium volume of bone.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
Clinica Reports 2002, Orthopaedics:Key markets & emerging technologies, CBS905E.
J. J. KLAWITTER and S. F. HULBERT, J. Biomed Mater. Res. 5 (1971) 161.
P. S. EGGLI, W. MULLER and R. K. SCHENK, Clin. Orthop. Relat. Res. 232 (1988) 127.
K. A. HING, S. M. BEST, K. E. TANNER, W. BONFIELD and P. A. REVELL, J. Biomed. Mater. Res. 68A (2004) 187.
R. E HOLMES, V. MOONEY, R. BUCHOLZ and A. TENCER, Clin. Orthop. Rel. Res. 188 (1984) 252.
J. J. KLAWITTER, J. G. BAGWELL, A. M. WEINSTEIN, B. W. SAUER and J. R. PRUITT, J. Biomed. Mater. Res. 10 (1976) 311.
J. H. KÚHNE, R. BARTL, B. FRISH, C. HANMER, V. JANSSON and M. ZIMMER, Acta Orthop. Scand. 65(3) (1994) 246.
P. A. RUBIN, J. K. POPHAM, J. R. BILYK and J. W. SHORE, Ophthal. Plast. Reconstr. Surg. 10(2) (1994) 96.
K. L. KILPADI, A. A. SAWYER, C. W. PRINCE, P. L. CHANG and S. L. BELLIS, J. Biomed. Mater. Res. 68A(2) (2004) 273.
J. WOLFF, Virchows Arch. Path. Anat. Physiol. 50 (1870).
H. M. FROST, Anat. Rec. 219(1) (1987) 1.
J. R. MAUNEY, S. SJOSTORM, J. BLUMBERG, R. HORAN, J. P. O’LEARY, G. VUNJAK-NOVAKOVIC, V. VOLLOCH and D. L. KAPLAN, Calcif. Tissue. Int. 74(5) (2004) 458.
B. ANNAZ, K. A. HING, M. V. KAYSER, T. BUCKLAND and L. DI SILVIO, J. Microscopy. 215(1) (2004) 100.
A. BIGNON, J. CHOUTEAU, J. CHEVALIER, G. FANTOZZI, J. P. CARRET, P. CHAVASSIEUX, G. BOIVIN, M. MELIN and D. HARTMANN, J. Mater. Sci. Mater. Med. 14(3) (2003)1089.
K. A. HING, S. SAEED, B. ANNAZ, T. BUCKLAND and P. A. REVELL, Key Engng. Mater. 254–256 (2004) 273.
A. BOYDE, A. CORSI, R. QUARTO, R. CANCEDDA and P. BIANCO, Bone 24(6) (1999) 579.
K. A. HING and W. BONFIELD, Foamed Ceramics, International Patent No. GB99/03283. (1999)
K. A. HING and T. BUCKLAND, Ceramic Biomaterial, UK Patent application No. 03258.33.2 (2003).
Powder diffraction file (PDF) 9-432, International centre for diffraction data, Newton Square Pensilvania USA
K. A. HING, S. M. BEST and W. BONFIELD, J. Mater. Sci. Mater. Med. 10(3) (1999) 135.
K. DONATH, J. Oral. Pathology 11 (1982) 318.
E. R. WEIBEL and H. E. ELIAS, in “Quantitative Methods in Morphology” (Springer-Verlag, Berlin 1967) p. 87.
K. A. HING, S. M. BEST, P. A. REVELL, K. E. TANNER and W. BONFIELD, Proc. Instn. Mech. Engrs. Part. H 212 (1998) 437.
H. M. FROST in “Bone Histomorphometry” edited by P.J. Meunier (1976) p. 361.
S. OHTSUBO, M. MATSUDA and M. TAKEKAWA, Histol Histopathol. 18(1) (2003) 153.
J. A. O’CONNOR, L. E. LANYON and J. H. MACFIE, J. Biomech. 15 (1982) 767.
L. E. LANYON, A. E. GOODSHIP, C. J. PIE and J. H, ibid. 15(3) (1982) 141.
D. B. BURR, R. B. MARTIN, M. B. SCHAFFLER and E. L. RADIN, ibid. 18 (1985)189.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hing, K.A., Annaz, B., Saeed, S. et al. Microporosity enhances bioactivity of synthetic bone graft substitutes. J Mater Sci: Mater Med 16, 467–475 (2005). https://doi.org/10.1007/s10856-005-6988-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10856-005-6988-1